First Tracks Biotherapeutics, Inc. (TRAX) First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
First Tracks Biotherapeutics Inc NASDAQ:TRAX Healthcare · Biotechnology
AH Close $43.97 vs close AH Close $43.97 -0.18% vs close
8-K 10-Q S-1 S-8 3 3/A 4 4/A 13G 144 424B3 UPLOAD CORRESP
Form Description Filed Links 8-K 10/20/26 Oct 20, 2026 8-K 10/15/26 Oct 15, 2026 8-K 10/13/26 Oct 13, 2026 4 Statement of Changes in Beneficial Ownership
9/17/26 Sep 17, 2026 4 Statement of Changes in Beneficial Ownership
9/4/26 Sep 4, 2026 144 Notice of Proposed Sale of Securities
9/2/26 Sep 2, 2026 4 Statement of Changes in Beneficial Ownership
8/18/26 Aug 18, 2026 4 Statement of Changes in Beneficial Ownership
8/18/26 Aug 18, 2026 4 Statement of Changes in Beneficial Ownership
8/18/26 Aug 18, 2026 13G Beneficial Ownership Report
8/14/26 Aug 14, 2026 13G Beneficial Ownership Report
8/14/26 Aug 14, 2026 13G Beneficial Ownership Report
8/13/26 Aug 13, 2026 424B3 8/13/26 Aug 13, 2026 10-Q 8/12/26 Aug 12, 2026 8-K 8/12/26 Aug 12, 2026 3/A Initial Statement of Beneficial Ownership
8/7/26 Aug 7, 2026 3/A Initial Statement of Beneficial Ownership
8/7/26 Aug 7, 2026 3/A Initial Statement of Beneficial Ownership
8/7/26 Aug 7, 2026 13G Beneficial Ownership Report
8/6/26 Aug 6, 2026 4 Statement of Changes in Beneficial Ownership
8/5/26 Aug 5, 2026 4 Statement of Changes in Beneficial Ownership
8/5/26 Aug 5, 2026 4 Statement of Changes in Beneficial Ownership
8/5/26 Aug 5, 2026 13G Beneficial Ownership Report
7/28/26 Jul 28, 2026 8-K 6/22/26 Jun 22, 2026 4 Statement of Changes in Beneficial Ownership
6/17/26 Jun 17, 2026
